{"id":"NCT01515423","sponsor":"Janssen Research & Development, LLC","briefTitle":"Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia","officialTitle":"A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05","primaryCompletion":"2015-02","completion":"2015-03","firstPosted":"2012-01-24","resultsPosted":"2016-05-02","lastUpdate":"2016-05-02"},"enrollment":1429,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"PP3M 175 mg eq.","otherNames":[]},{"type":"DRUG","name":"PP3M 263 mg eq.","otherNames":[]},{"type":"DRUG","name":"PP3M 350 mg eq.","otherNames":[]},{"type":"DRUG","name":"PP3M 525 mg eq.","otherNames":[]},{"type":"DRUG","name":"Placebo (20% Intralipid)","otherNames":[]},{"type":"DRUG","name":"PP1M 50 mg eq.","otherNames":[]},{"type":"DRUG","name":"PP1M 75 mg eq.","otherNames":[]},{"type":"DRUG","name":"PP1M 100 mg eq.","otherNames":[]},{"type":"DRUG","name":"PP1M 150 mg eq.","otherNames":[]}],"arms":[{"label":"Paliperidone palmitate 3-month (PP3M)","type":"EXPERIMENTAL"},{"label":"Paliperidone palmitate 1-month (PP1M)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to demonstrate that a paliperidone palmitate 3 month formulation (PP3M) is as effective as the paliperidone palmitate 1 month formulation (PP1M) in the treatment of patients with schizophrenia who have been stabilized on PP1M.","primaryOutcome":{"measure":"Percentage of Participants Without Relapse at Week 48 During the Double-Blind Phase","timeFrame":"Up to 48 weeks","effectByArm":[{"arm":"Double Blind: Paliperidone Palmitate 3 Month Formulation","deltaMin":91.5,"sd":null},{"arm":"Double Blind: Paliperidone Palmitate 1 Month Formulation","deltaMin":90,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":174,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","China","Czechia","France","Germany","Greece","Hungary","Japan","Mexico","Poland","Portugal","Romania","Russia","Slovakia","South Korea","Spain","Sweden","Taiwan","Ukraine"]},"refs":{"pmids":["38190077","32184607","30994855","30962688","29882073","27743205","27333588"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":101,"n":1429},"commonTop":["Weight Increased","Injection Site Pain","Nasopharyngitis","Insomnia","Anxiety"]}}